Circulation Research, Vol 36, 599-609, Copyright © 1975 by American Heart Association
ARTICLES |
KU Malik and JC McGiff
In the isolated perfused rabbit kidney prostaglandins (PGS) E1 (0.02-0- 1 ng/ml), E2 (0.02-0.1 ng/ml), and A2 (1-5 ng/ml) inhibited the vasoconstrictor responses to sympathetic nerve stimulation by 21-44%, 31-39%, and 20-23%, respectively, without alerting those to injected norepinephrine. In contrast, in the rat kidney PGE1 (0.5 ng/ml), PGE2 (0.5 ng/ml), and PGA2 (5 ng/ml) enhanced the vasoconstrictor responses to sympathetic nerve stimulation by 41%, 27%, and 11%, respectively; the equiconstrictor responses to injected norepinephrine remained unaltered. Higher concentrations of these agents produced vasodilation in the rabbit kidney and vasoconstriction in the rat kidney. In both species PGF2alpha produced vasoconstriction and enhanced the response to both adrenergic stumuli. In the rabbit kidney inhibitors of PG synthesis augmented the responses to sympathetic nerve stimulation without altering those to injected norepinephrine, whereas in the rat kidney inhibition of the responses to both adrenergic stimuli occurred. Arachidonic acid inhibited the vasoconstrictor responses to sympathetic nerve stimulation in the rabbit kidney, but in the rat kidney it caused augmentation of these responses. Since these effects of arachidonic acid were reduced by indomethacin, they appear to be mediated through the acid's conversion to PGS. We conclude that PGS of the E series modulate adrenergic transmission in the kidney and that their modulatory actions are species dependent.
This article has been cited by other articles:
![]() |
A. O. Oyekan Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan Contributions of Nitric Oxide and Prostanoids and Their Signaling Pathways to the Renal Medullary Vasodilator Effect of U46619 (9-11-Dideoxy-11{alpha},9a-Epoxymethano-Prostaglandin F2a) in the Rat J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 507 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamasaki, I. Tamai, and Y. Matsumura Activation of histamine H3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1450 - R1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Audoly, X. Ruan, V. A. Wagner, J. L. Goulet, S. L. Tilley, B. H. Koller, T. M. Coffman, and W. J. Arendshorst Role of EP2 and EP3 PGE2 receptors in control of murine renal hemodynamics Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H327 - H333. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Black Renal Toxicity of Non-Steroidal Anti-Inflammatory Drugs Toxicol Pathol, January 1, 1986; 14(1): 83 - 90. [Abstract] [PDF] |
||||
![]() |
J. C. McGIFF Bartter's Syndrome Results from an Imbalance of Vasoactive Hormones Ann Intern Med, September 1, 1977; 87(3): 369 - 372. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |